Lunesta, Crestor, Sanctura Among New Products In UnitedHealth Registry
Executive Summary
Sepracor's insomnia agent Lunesta, AstraZeneca's statin Crestor and Indevus' overactive bladder therapy Sanctura are among the new products to be included in UnitedHealth's postmarketing surveillance drug registry
You may also be interested in...
Atrovent, Spiriva Safety To Be Tracked In Pharmacy Active Surveillance Pilot
An active drug surveillance system pilot, directed by the Critical Path Institute (C-Path), will track safety and efficacy information for the chronic obstructive pulmonary disorder therapies Atrovent and Spiriva
Atrovent, Spiriva Safety To Be Tracked In Pharmacy Active Surveillance Pilot
An active drug surveillance system pilot, directed by the Critical Path Institute (C-Path), will track safety and efficacy information for the chronic obstructive pulmonary disorder therapies Atrovent and Spiriva
UnitedHealth Rx Registry Will Test Four Highest Prescribed NMEs In 2004
UnitedHealth is testing its new postmarketing surveillance drug database on the four most frequently prescribed new molecular entities launched in 2004